Advertisements



Dispatches from a Pandemic: The public’s expectation of perfection: Risk of blood clot from Johnson & Johnson COVID-19 vaccine is 0.00009%

‘It’s the same perceptual problem when we blindly drive to the airport texting, yet worry about the airplane.’.....»»

Category: topSource: marketwatchApr 19th, 2021

Dispatches from a Pandemic: The expectation of perfection: Risk of blood clot from Johnson & Johnson COVID-19 vaccine is 0.00009%

‘It’s the same perceptual problem when we blindly drive to the airport texting, yet worry about the airplane.’.....»»

Category: topSource: marketwatchApr 17th, 2021

Dispatches from a Pandemic: ‘It was a wise decision to spread the risk’: Johnson & Johnson saga reveals vulnerabilities in COVID-19 vaccine strategy

“It’s still a race between the variants and the vaccine,” said Amesh Adalja, a senior scholar at the John Hopkins Center for Health Security......»»

Category: topSource: marketwatchApr 14th, 2021

Dispatches from a Pandemic: ‘It was a wise decision to spread the risk’: What Johnson & Johnson saga reveals about COVID-19 vaccination campaign

“It’s still a race between the variants and the vaccine,” said Amesh Adalja, a senior scholar at the John Hopkins Center for Health Security......»»

Category: topSource: marketwatchApr 14th, 2021

Johnson & Johnson Rises on 1st-Quarter Earnings Beat

Company reports solid Covid-19 vaccine sales despite blood clot issuesRelated Stocks: JNJ,.....»»

Category: smallbizSource: nytApr 20th, 2021

Johnson & Johnson asked other drugmakers to help it study blood-clot risks, and Moderna and Pfizer refused, report says

J&J privately contacted rival drugmakers also producing COVID-19 vaccines to join the study, and only AstraZeneca agreed, WSJ reports. Johnson & Johnson privately contacted other drugmakers producing COVID-19 vaccine to join a study into the p.....»»

Category: smallbizSource: nytApr 16th, 2021

Dispatches from a Pandemic: Johnson & Johnson and AstraZeneca sagas illustrate strength of COVID-19 strategy: ‘It was a wise decision to spread the risk’

‘Factories can be hit by a hurricane, run out of a supply, or be hit by contamination that forces them to shut down.’.....»»

Category: topSource: marketwatchApr 15th, 2021

Dispatches from a Pandemic: What Johnson & Johnson and AstraZeneca’s problems reveal about the COVID-19 mass-vaccination campaign

‘It was a wise decision to spread the risk. Factories can be hit by a hurricane, run out of a supply, or be hit by contamination that forces them to shut down.’.....»»

Category: topSource: marketwatchApr 14th, 2021

Dispatches from a Pandemic: Johnson & Johnson and AstraZeneca problems are not unexpected — it would be more unusual to have NO vaccine problems

‘It was a wise decision to spread the risk. Factories can be hit by a hurricane, run out of a supply, or be hit by contamination that forces them to shut down.’.....»»

Category: topSource: marketwatchApr 14th, 2021

Will the pause of Johnson & Johnson"s Covid-19 vaccine cause Arizona employers to back off vaccine mandates?

Will employers slow their efforts to mandate the Covid-19 vaccine at a time when one vaccine is being halted amid blood clot concerns? Here's what experts in Arizona are saying......»»

Category: topSource: bizjournalsApr 14th, 2021

The US is pausing the Johnson & Johnson coronavirus vaccine rollout, citing the risk of rare blood clots

The US will stop distributing the Johnson & Johnson vaccine temporarily while federal agencies investigate a potential link to blood clots. A nurse loading a syringe with a dose of Johnson & Johnson's COVID-19 vacc.....»»

Category: personnelSource: nytApr 13th, 2021

Market Snapshot: Tech shares rise but Dow under pressure as U.S. pauses Johnson & Johnson COVID vaccine rollout

U.S. stocks trade mixed Tuesday morning after U.S. public-health agencies requested a temporary halt in the use of Johnson & Johnson's one-shot COVID vaccine out of “an abundance of caution” due to extremely rare blood-clotting issues......»»

Category: topSource: marketwatchApr 13th, 2021

100 million doses of Johnson & Johnson"s vaccine need to be checked for contamination and may need to be thrown out

The millions of Johnson & Johnson COVID-19 vaccine doses haven't been distributed to the public and are from a plagued Emergent BioSolutions facility. Employees wor.....»»

Category: dealsSource: nytMay 19th, 2021

The Margin: Johnson & Johnson vaccine pause: What to know if you got or scheduled the shot

A CDC advisory committee recommends lifting the pause. So what blood clot symptoms should you watch out for if you get the vaccine?.....»»

Category: topSource: marketwatchApr 23rd, 2021

The US is resuming its rollout of Johnson & Johnson"s vaccine after a pause to investigate blood clots

The COVID-19 shot will now come with a warn.....»»

Category: topSource: businessinsiderApr 23rd, 2021

CDC panel says Johnson & Johnson"s COVID-19 shot can be used again

Rare but potentially fatal blood clot.....»»

Category: topSource: businessinsiderApr 23rd, 2021

: J&J resumes European COVID-19 vaccine rollout with regulator-mandated safety warning

The European Medicines Agency demanded that a “warning about unusual blood clots with low blood platelets” be included in the product information of the Johnson & Johnson COVID-19 shots......»»

Category: topSource: marketwatchApr 21st, 2021

Johnson & Johnson jumps as vaccine shipments to Europe set to resume after regulator says benefits outweigh blood clot risks

Johnson & Johnso.....»»

Category: topSource: businessinsiderApr 20th, 2021

Johnson & Johnson coronavirus vaccine should have warning labels about rare blood clots, but benefits outweigh risk, European agency says

The European Medicines Agency said these rare blood disorders should be considered as “very rare side effects of the vaccine.”The European Medicines Agency said these rare blood disorders should be considered as “very rare side effects of the vaccine.”.....»»

Category: topSource: chicagotribuneApr 20th, 2021

Johnson & Johnson vaccine should get blood-clot warning, European agency says

The European Medicines Agency said its safety committee concl.....»»

Category: topSource: marketwatchApr 20th, 2021

US officials may need 2 weeks or more to determine if Johnson & Johnson"s vaccine causes rare blood clots

The CDC still might not have enough data to evaluate a blood clot link by its Friday meeting, two senior health officials told Poli.....»»

Category: worldSource: nytApr 17th, 2021